Forest Decision Does Little To Remove Exclusion Threat
While U.S. health care regulators have backed down from their bold threat to ban Forest Laboratories Inc.'s CEO from contracting with the government in the wake of the drugmaker's alleged off-label...To view the full article, register now.
Already a subscriber? Click here to view full article